Cyclin Inhibitor Therapy (Circle Pharma/Boehringer Ingelheim)

N/A

Report date: 2025/01/09 14:49:26
NMEFirst In Class

Base Information

Drug NameCyclin Inhibitor Therapy (Circle Pharma/Boehringer Ingelheim)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclins inhibitors
TargetsCyclins
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCircle Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgCircle Pharma Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A